These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15795233

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets.
    Hirao A, Hamaguchi I, Suda T, Yamaguchi N.
    EMBO J; 1997 May 01; 16(9):2342-51. PubMed ID: 9171348
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. GPVI potentiation of platelet activation by thrombin and adhesion molecules independent of Src kinases and Syk.
    Hughan SC, Hughes CE, McCarty OJ, Schweighoffer E, Soultanova I, Ware J, Tybulewicz VL, Watson SP.
    Arterioscler Thromb Vasc Biol; 2007 Feb 01; 27(2):422-9. PubMed ID: 17110603
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein.
    Sidorenko SP, Law CL, Chandran KA, Clark EA.
    Proc Natl Acad Sci U S A; 1995 Jan 17; 92(2):359-63. PubMed ID: 7831290
    [Abstract] [Full Text] [Related]

  • 29. Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2, 3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets.
    Bhavaraju K, Kim S, Daniel JL, Kunapuli SP.
    Eur J Pharmacol; 2008 Feb 12; 580(3):285-90. PubMed ID: 18068154
    [Abstract] [Full Text] [Related]

  • 30. Mildly oxidized low density lipoprotein rapidly stimulates via activation of the lysophosphatidic acid receptor Src family and Syk tyrosine kinases and Ca2+ influx in human platelets.
    Maschberger P, Bauer M, Baumann-Siemons J, Zangl KJ, Negrescu EV, Reininger AJ, Siess W.
    J Biol Chem; 2000 Jun 23; 275(25):19159-66. PubMed ID: 10764819
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The protein tyrosine kinase syk activity is reduced by clustering the mast cell function-associated antigen.
    Xu R, Pecht I.
    Eur J Immunol; 2001 May 23; 31(5):1571-81. PubMed ID: 11465115
    [Abstract] [Full Text] [Related]

  • 36. Catalytic specificity of phosphotyrosine kinases Blk, Lyn, c-Src and Syk as assessed by phage display.
    Schmitz R, Baumann G, Gram H.
    J Mol Biol; 1996 Aug 02; 260(5):664-77. PubMed ID: 8709147
    [Abstract] [Full Text] [Related]

  • 37. Tyrosine phosphorylation and translocation of LAT in platelets.
    Sarkar S.
    FEBS Lett; 1998 Dec 28; 441(3):357-60. PubMed ID: 9891970
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Translocation of p72syk to the cytoskeleton in thrombin-stimulated platelets.
    Tohyama Y, Yanagi S, Sada K, Yamamura H.
    J Biol Chem; 1994 Dec 30; 269(52):32796-9. PubMed ID: 7806502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.